These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9817388)

  • 41. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
    Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
    Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and pathological findings in testis, epididymis, deferens duct and prostate following vasectomy in a dog.
    Pérez-Marín CC; López R; Domínguez JM; Zafra R
    Reprod Domest Anim; 2006 Apr; 41(2):169-74. PubMed ID: 16519724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a non-androgenic role of testis and epididymis in androgen-supported growth of the rat ventral prostate.
    Darras FS; Lee C; Huprikar S; Rademaker AW; Grayhack JT
    J Urol; 1992 Aug; 148(2 Pt 1):432-40. PubMed ID: 1635154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of mepartricin (S-160) on spontaneous canine benign prostatic hyperplasia.
    Yoshinaka Y; Kobayasi H; Kirihara J; Sato F; Shakutou S; Yamanaka H
    Eur Urol; 2000 Apr; 37(4):428-35. PubMed ID: 10765073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
    Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH
    Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Origin and evolution of benign prostatic enlargement.
    McNeal JE
    Invest Urol; 1978 Jan; 15(4):340-5. PubMed ID: 75197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testosterone and Benign Prostatic Hyperplasia.
    Rastrelli G; Vignozzi L; Corona G; Maggi M
    Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computed Tomography of the Prostate Gland in Healthy Intact Dogs and Dogs with Benign Prostatic Hyperplasia.
    Pasikowska J; Hebel M; Niżański W; Nowak M
    Reprod Domest Anim; 2015 Oct; 50(5):776-83. PubMed ID: 26303126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [5 alpha-reductase and prostate].
    Lobaccaro JM; Boudon C; Lumbroso S; Lechevallier E; Mottet N; Rebillard X; Sultan C
    Ann Endocrinol (Paris); 1997; 58(5):381-92. PubMed ID: 9685996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].
    Kinoshita H; Habuchi T; Ogawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():23-7. PubMed ID: 12599539
    [No Abstract]   [Full Text] [Related]  

  • 56. Androgen receptors in male sex tissues of rats and humans.
    Attramadal A; Weddington SC; Naess O; Djoseland O; Hansson V
    Prog Clin Biol Res; 1976; 6():189-203. PubMed ID: 66689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign Prostatic Hyperplasia: Long-term follow-up of prostate volume reduction after sclerotherapy of the internal spermatic veins.
    Gat Y; Goren M
    Andrologia; 2018 Mar; 50(2):. PubMed ID: 28948696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The chimpanzee as a model of human benign prostatic hyperplasia.
    Steiner MS; Couch RC; Raghow S; Stauffer D
    J Urol; 1999 Oct; 162(4):1454-61. PubMed ID: 10492237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.